Invesco Dorsey Wright SmallCap Momentum ETF Rating $94.51 -1.32 (-1.38%) Closing price 10/21/2025 03:54 PM EasternExtended Trading$94.52 +0.00 (+0.01%) As of 10/21/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Dorsey Wright SmallCap Momentum ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.DWAS Aggregate RatingModerate Buy 2.72Holdings in DWAS have an aggregate rating of Moderate Buy based on 175 analyst ratings issued in the past year covering 25 companies (27.4% of the portfolio).DWAS Aggregate Price Target$94.51High Prediction$94.51Average Prediction$94.51Low Prediction$94.51Holdings in DWAS have an aggregate price target of $94.51 and a range of $94.51 to $94.51 covering 25 companies (27.4% of the portfolio).DWAS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Dorsey Wright SmallCap Momentum ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 DWAS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.60%ONDSOndas$7.19-7.5%1.1207 of 5 stars2.60$7.25 0.8%5Gap Up1.50%AMPXAmprius Technologies$12.23-9.6%2.0226 of 5 stars2.78$13.14 7.5%9Gap Up1.40%BMNRBitMine Immersion Technologies$51.85-3.6%2.4411 of 5 stars3.00$90.00 73.6%3Analyst RevisionGap Down1.39%CDTXCidara Therapeutics$103.22+2.6%3.9616 of 5 stars2.92$151.33 46.6%12Analyst Forecast1.38%TDUPThredUp$8.98-4.1%2.9618 of 5 stars2.67$13.00 44.8%6Short Interest ↑1.29%LEUCentrus Energy$377.01-5.7%1.1774 of 5 stars2.69$202.09 -46.4%13Positive NewsGap Down1.27%PRCHPorch Group$15.50-1.0%2.5486 of 5 stars2.82$16.56 6.8%11News Coverage1.25%BELFBBel Fuse$148.00+0.0%3.4706 of 5 stars3.14$138.40 -6.5%7Upcoming Earnings1.24%OPENOpendoor Technologies$6.96-5.6%2.6025 of 5 stars1.67$2.21 -68.2%6Analyst Forecast1.22%CLMBClimb Global Solutions$129.96-0.5%1.9221 of 5 stars3.00$136.00 4.6%2Upcoming Earnings1.19%APEIAmerican Public Education$37.62+0.3%4.2342 of 5 stars2.80$38.29 1.8%101.15%TPCTutor Perini$66.90-0.3%1.8083 of 5 stars2.40$60.00 -10.3%51.13%DAKTDaktronics$19.91-0.4%4.9362 of 5 stars3.00$26.00 30.6%31.08%AMLXAmylyx Pharmaceuticals$15.29-0.5%2.5404 of 5 stars2.86$16.75 9.5%14Gap Up1.03%XGNExagen$11.69-0.3%4.2877 of 5 stars2.78$12.60 7.8%9News CoverageInsider Trade0.97%HWKNHawkins$163.72+0.3%3.0552 of 5 stars2.60$162.50 -0.7%5Positive NewsUpcoming Earnings0.86%NBNNortheast Bancorp$93.99-0.2%3.6141 of 5 stars2.50$115.00 22.4%2News Coverage0.86%NKTRNektar Therapeutics$59.38-5.7%3.998 of 5 stars2.63$91.67 54.4%80.85%PLPlanet Labs PBC$12.91-4.8%1.7045 of 5 stars2.58$11.26 -12.8%12Trending NewsAnalyst ForecastAnalyst RevisionGap Down0.84%TNGXTango Therapeutics$8.99-1.7%1.4777 of 5 stars2.67$10.50 16.8%60.81%GRBKGreen Brick Partners$68.69+1.6%1.7658 of 5 stars2.00$66.00 -3.9%3News CoveragePositive News0.80%ENVAEnova International$111.46+1.8%3.0186 of 5 stars3.00$111.00 -0.4%8News CoverageUpcoming Earnings0.79%IDCCInterDigital$372.17+0.3%2.4269 of 5 stars3.00$345.00 -7.3%4Positive News0.77%AMRXAmneal Pharmaceuticals$10.29+0.5%2.068 of 5 stars2.80$12.00 16.6%50.77%CCBCoastal Financial$103.40-0.1%4.048 of 5 stars3.00$116.20 12.4%7Upcoming Earnings This page (NASDAQ:DWAS) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Dorsey Wright SmallCap Momentum ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Dorsey Wright SmallCap Momentum ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.